Harmony Biosciences Holdings, Inc.
HRMY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $1 | $1 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 19.4% | 8.5% | -8.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.1% | 81% | 82.7% | 73% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 30.7% | 29.6% | 36.3% | 33% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 21.2% | 19.8% | 24.7% | 24.6% |
| EPS Diluted | 0.87 | 0.68 | 0.78 | 0.85 |
| % Growth | 27.9% | -12.8% | -8.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |